When Cruise two results r released, management can then data mine and compare long term open label study with cruise results. This mornings release is big in that, this is what management believes the data will reveal and confirm. If SPF can be confirmed to reduce ESAs by 35% and ESAs are a 2+ billion $ a year industry management states there is a cost savings of 700 million a year...which for a company with under a $200 mkt cap would be exponential returns. The abstract topics should stir publicity, anticipation and speculation from brokerages and investors alike.
For those unaware investors or those not invested in RMTI, it adds to ( or confirms) three HUGE catalysts within the next three months. Cruise 2, Calcitriol, and the data mining release. These abstracts are possibly this most influential to the stock price. Also, consider with each successful catalyst into November there will be new coverage by larger firms and upgrades.